TNF and tuberculosis: To evaluate the risk of infection using anti-TNF-α strategies, we compared a vaccine directed against murine TNF-α we developed by coupling murine TNF-α to KLH (TNFKi) and etanercept, the anti-TNF-α treatment associated with the lowest occurrence of infections, namely iatrogenic tuberculosis (12, 13).